Drug Research
Drug Discovery & Development

Case Study: Supplying Costly Investigational Product: Pre-Randomisation Approach Reduces Drug Wastage

Published 24 September 2015 | By Almac

Certainly, every sponsor wants to minimise wastage in clinical trial supplies, but the motivation to do so is extraordinary when the product under study is unusually expensive. A top-tier, international pharmaceutical company engaged Almac to ensure that it did not incur undue drug supply costs for a global study involving a very expensive investigational product. With some ingenuity and customisations to the IXRS® platform for managing patients, supplies, and trial data, Almac helped the client re-envision its study design and supply strategy.

For more information, click here